Rational psycho-pharmacology for patients with medical diseases.
D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000627:therapeutic use; D000929:Antidepressive Agents, Tricyclic / Q000009:adverse effects; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use; D001007:Anxiety / Q000150:complications / Q000188:drug therapy; D001145:Arrhythmias, Cardiac / Q000139:chemically induced; D003327:Coronary Disease / Q000150:complications; D004827:Epilepsy / Q000188:drug therapy; D006801:Humans; D006973:Hypertension / Q000150:complications; D006993:Hypnotics and Sedatives / Q000627:therapeutic use; D008107:Liver Diseases / Q000378:metabolism; D008173:Lung Diseases, Obstructive / Q000150:complications; D010437:Peptic Ulcer / Q000378:metabolism; D011619:Psychotropic Drugs / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D012131:Respiratory Insufficiency / Q000139:chemically induced / Q000150:complications; D013923:Thromboembolism / Q000378:metabolism
D014151:Anti-Anxiety Agents; D000928:Antidepressive Agents; D000929:Antidepressive Agents, Tricyclic; D014150:Antipsychotic Agents; D006993:Hypnotics and Sedatives; D011619:Psychotropic Drugs